APP and Alzheimer disease: Another study on the effect of mTOR inhibition via rapamycin in an APP/PS1 mouse model of AD revealed that treatment with rapamycin inhibited mTOR, which consequently led to a decrease in the expression of SASP markers and increased expression of autophagy markers.